T o determine the effects of sucrose-enriched feeds on somatic growth, blood pressure development, and insulinstimulated glucose metabolism, Sprague-Dawley rat pups (n = 94) were randomly assigned at weaning (3 wk) to a control diet (15% sucrose, by calories, n = 48) or an isocaloric diet in which starch is replaced by sucrose (66% sucrose, by calories, n = 46). Weight and blood pressure were followed until 13 wk. Chronic catheters were placed in a subset of male animals (n = 13), fasting glucose production was measured, and euglycemic hyperinsulinemic clamps were performed while the rats were in the conscious, nonstressed state. There was no difference in weight gain between control and sucrose rats in each sex group. Blood pressure in sucrose rats was significantly higher than in control rats after 4 wk of diet (7 wk of age,p < 0.001) in both Insulin resistance is defined as a suboptimal biologic response to insulin (1). Data from epidemiologic studies have shown an association of hyperinsulinemia (indicating insulin resistance) with hypertension, independent of obesity and non-insulin-dependent diabetes mellitus (2, 3). Clinical investigations on insulin-mediated glucose metabolism using the euglycemic hyperinsulinemic clamp technique (4, 5) have confirmed in nonobese, nondiabetic patients with essential hypertension the presence of both hyperinsulinemia and insulin resistance in peripheral tissue.
T o determine the effects of sucrose-enriched feeds on somatic growth, blood pressure development, and insulinstimulated glucose metabolism, Sprague-Dawley rat pups (n = 94) were randomly assigned at weaning (3 wk) to a control diet (15% sucrose, by calories, n = 48) or an isocaloric diet in which starch is replaced by sucrose (66% sucrose, by calories, n = 46). Weight and blood pressure were followed until 13 wk. Chronic catheters were placed in a subset of male animals (n = 13), fasting glucose production was measured, and euglycemic hyperinsulinemic clamps were performed while the rats were in the conscious, nonstressed state. There was no difference in weight gain between control and sucrose rats in each sex group. Blood pressure in sucrose rats was significantly higher than in control rats after 4 wk of diet (7 wk of age,p < 0.001) in both Insulin resistance is defined as a suboptimal biologic response to insulin (1) . Data from epidemiologic studies have shown an association of hyperinsulinemia (indicating insulin resistance) with hypertension, independent of obesity and non-insulin-dependent diabetes mellitus (2, 3). Clinical investigations on insulin-mediated glucose metabolism using the euglycemic hyperinsulinemic clamp technique (4, 5) have confirmed in nonobese, nondiabetic patients with essential hypertension the presence of both hyperinsulinemia and insulin resistance in peripheral tissue.
Recent experimental studies have shown that hypertension, without obesity, can be induced in 8-to 9-wk-old Sprague-Dawley rats after only 2 wk of a diet in which complex carbohydrate is replaced with fructose (6, 7). The presence of insulin resistance, as measured by the insulin suppression test, is concurrent with blood pressure elevation in these rats. Because of the preponderance of sugar in contemporary American diets (8, 9), receive control rat food or rat food in which starch Measurement of Hepatic Endogenous Glucose Production (dextrin) was replaced with sucrose (components of the and Insulin-Stimulated Glucose Metabolism diet are described in Table 1 ). control-and sucroseenriched diet pellets were isocaloric (15.1 kJIg, or 3.60 callg). The animals had free access to water. They were housed in a room with a 12-h lightldark cycle. Food consumption was measured and caloric intake was calculated three times per week. Animals were weighed weekly. When the pups weighed about 75 g, they began training for indirect tail-cuff blood pressure determination (model 99, IITC Life Sciences Inst., Woodland Hills, CA). Validation of blood pressure determination by tail plethysmography in rats has been described by Budag (12). The instrument had previously been validated in our laboratory with intraarterial measurements. Stable blood pressure measurements were achieved by 6 wk of age. Thereafter, blood pressure and weight were determined on the same day, once per week. The weekly blood pressure for each animal that was used in the statistical analysis was the mean of four to six readings per session.
To evaluate insulin sensitivity after 10 wk of diet (age 13 wk), insulin-stimulated glucose metabolism was measured with the euglycemic hyperinsulinemic clamp. A subset of male animals underwent surgery for implantation of chronic catheters. Females were not used for the clamp study because their relative small size at 13 wk (250 g) resulted in great difficulty with catheter implantation. After intraperitoneal anesthesia with acepromazine, ketamine, and xylazine, one small (0.5-cm) midline incision was made, which permitted catheterization of the internal jugular vein (Silastic medical grade, Becton Dickinson, Parsippany, NJ) and the contralateral carotid artery (PE 10, Becton Dickinson). The catheters were exteriorized to the ventral surface of the neck and sealed with a viscous solution of polyvinylpyrrolidone (PVP-10, Sigma, St. Louis, MO). The catheters required no further care before surgery, until the time of the clamp study, when the PVP-10 was slowly flushed through the catheters to establish patent access to the vessels. The animals recovered from surgery in a neonatal incubator, which prevented postoperative hypothermia. Each rat was studied after it had regained preoperative weight, which was usually 72 h after surgery. The rat was fully conscious, unrestrained, and remained quiet for the duration of the study. After a 12-h fast, measurement of fasting endogenous glucose production was made with the tracer dilution method before the imposition of euglycemic hyperinsulinemia. A primed constant infusion of tritiated glucose (prime = 1 pCi, infusion = 0.1 pCi1 rnin of D-6-'H-glucose, New England Nuclear, Boston, MA) was delivered through the arterial catheter and continued for 60 min (13). During the final 10 min of 6-%I-glucose infusion, three samples were withdrawn, and the plasma was isolated by centrifugation. Portions of the three plasma samples were analyzed immediately for glucose concentration by the glucose oxidase method (Glucostat, model 27, Yellow Springs Instrument Co., Yellow Springs, OH). Another portion of the plasma sample was used for the measurement of GSA, and the remainder was immediately frozen at -20°C for subsequent RIA of plasma insulin concentration (see below).
Euglycemic hyperinsulinemia was then instituted with a simultaneous infusion of insulin (regular human insulin, Eli Lilly, Indianapolis, IN) at about 30 pmol/kg/min (4.0 mU/kg/min) and glucose (20% dextrose), according to previously reported methods (14). Infusion of tritiated glucose continued during euglycemic hyperinsulinemia to determine the effect of hyperinsulinemia on endogenous glucose production. Euglycemic hyperinsulinemia was maintained for 90 min. During the final 10 min, three samples were withdrawn for measurement of plasma GSA and insulin concentration, as well as plasma glucose concentration.
Assays
Glucose. Plasma glucose concentration was measured with the glucose oxidase method, as noted above. The precise concentration of glucose in the 20% dextrose infusate was measured, and this concentration was used to determine glucose infusion rate.
Insulin. Plasma insulin was measured with RIA (DPC Coat-A-Count, Los Angeles, CA), using a human standard. Rat insulin and human insulin differ by only three amino acid residues, so cross-reactivity of the human antibody and rat antigen should be present. To ensure that cross-reactivity was occurring, RIA of serial dilutions of fasting rat plasma was performed with human antibody and compared to a human insulin standard curve. There was parallel displacement of the rat plasma curve, indicating cross-reactivity of the two species. Consequently, human standard can be used for both fasting rat plasma, as well as "clamped" rat plasma. Plasma insulin concentration is expressed as pmol1L.
GSA. GSA was determined with the Somogyi method (15). Briefly, rat plasma samples (0.05 mL) were deproteinized with 0.100 m L each of 0.1 N ZnSO, and 0.1 N Ba(OH),. After a 30-min room temperature incubation, 0.05 m L of supernatant was dried overnight (to evaporate tritiated water). The samples were reconstituted with 0.05 m L of distilled water. After addition of 10 mL of Ecolume (ICN, Irvine, CA), a water-soluble biodegradable scintillation cocktail, counts were determined in a liquid scintillation counter (Beckman Instruments, Fullerton, CA). After correction for quenching, cpmtml were determined for each sample. GSA in the fasting state was calculated by determining the quotient of corrected countstml and glucose concentration from the three samples withdrawn at the end of the first 90 min. The calculation of glucose turnover (or R,) in the fasting state was performed with the equation of Steele (16) (R, = infusion rate of tracertspecific activity of tracer) and was based on the assumption of achievement of a steady state. R, is expressed in mmol/kg/min. It is recognized that the Steele equation (16) underestimates the rate of glucose turnover in the fasting state (17). Because some tritium from 6-3~-glucose is lost to lactate, underestimation of R, arises from the contribution of counts derived from tritiated lactate, which was not chromatographically removed in this protocol. According to Dunn e t al. (18), 19% of tritium counts are lost from glucose to lactate when 6-3~-glucose is used. However, in the study reported here, all samples were processed in the same way, so the error is systematic and the same in both feed groups.
GSA during hyperinsulinemia was determined from the three samples withdrawn at the end of the clamp, with the methods described above. Hepatic endogenous glucose production during euglycemic hyperinsulinemia was calculated as the difference between the R, of glucose (R, = infusion rate of tracertspecific activity of tracer) and the glucose infusion rate required to maintain euglycemia. It is recognized that this method underestimates the R, of glucose during euglycemic hyperinsulinemia because GSA is contaminated with tritiated lactate (see above), but as with the determination of R, described above, all samples were processed in the same way, so the systematic error is the same in both strains. This underestimation of R, may lead to negative numbers if glucose infusion rate exceeds R,, which is interpreted as complete suppression of hepatic endogenous glucose production (19).
Statistical Methods
Mean blood pressure, weight, and fasting metabolic variables in the two feed groups were compared with the t test. Metabolic variables during euglycemic hyperinsulinemia were analyzed with two-way ANOVA, followed by Scheffe's test for pairwise comparisons. Results are expressed as mean & SD.
RESULTS
Data are available from 50 males and 44 females. Males included 26 fed the control diet and 24 fed the sucrose diet. Females were randomized to 22 fed the control diet and 22 fed the sucrose diet.
Somatic growth. Somatic growth for both control and sucrose males and females is depicted in Figure 1 . Although weight and weight gain were significantly greater in males than in females, within sex groups there was no difference in growth conferred by type of diet (two-way ANOVA). Total food consumption was also the same in both male groups and in both female groups; therefore, the only difference between the feed groups was intake of sucrose. Caloric, protein, fat, and mineral intake were the same between the feed groups.
Blood pressure. Figure 2 depicts mean blood pressure for all four groups of rats during the 10-wk experimental period. The upper panel depicts both male feed groups; the lower panel, both female feed groups. Several findings are apparent from this figure: 1 ) Both male groups (upperpanel), as well as sucrose females (lower panel), demonstrated a significant rise in blood pressure over the 10-wk diet period (ANOVA: control males: F = 1 5 . 7 ,~ < 0.0001; sucrose males: F = 31.6, p < 0.0001; sucrose females: F = 8.41, p c 0.0001). Control females did not show a statistically significant rise in blood pressure over the 10-wk diet period ( F = 1 . 6 1 ,~ = 0.12). 2) The rise in blood pressure in sucrose males was significantly greater than in control males (two-way ANOVA, p < 0.0001). Sucrose females had significantly greater blood pressure than control females from wk 7 through 13, despite a decline in blood pressure in sucrose females after 9 wk (two-way ANOVA, p < 0.0001). 3) Blood pressure in sucrose males and sucrose females was not different from wk 4 through 10. After wk 10, blood pressure in sucrose males was significantly higher than in sucrose females @ < 0.005).
Insulin-stimulated glucose metabolism. Fasting and insulin-stimulated glucose metabolism (clamp) studies were performed in 13 males (seven control, six sucrose) at age Figure 1 . In each sex, mean weekly blood pressure in both diet groups increased significantly from wk 4 to 13. Mean blood pressure in sucrose-fed males was significantly greater than in control males from wk 7 through 13 (ANOVA, p < 0.0001). Mean blood pressure in sucrose-fed females was significantly greater than in control females from wk 7 through 13, despite decreasing means in sucrose females during wk 10 through 14 (ANOVA, p < 0.0001).
13 wk. Fasting data are presented in Our data show that R, was somewhat greater in sucrose rats compared with controls; however, the difference was not statistically significant, with comparable standard deviations in both groups. Furthermore, despite the potential errors in the measurement of glucose production, the data reported here are consistent with earlier reports on conscious, chronically catheterized rats (13, 21). The data also indicate that both groups of animals did not experience a stress response. Table 3 presents clamp metabolic data. Clamp plasma glucose and insulin concentrations were statistically similar in both groups; however, clamp plasma glucose concentration was more variable in the sucrose-fed animals than in the control-fed animals. During the clamp, tight control of plasma glucose concentration was more difficult in the sucrose-fed animals than in the controls, because the animals did not recover rapidly from an overdetermination of the glucose infusion rate. The comparative lack of rapid recovery in control of clamped glucose concentration may have been the result of reduced insulin-stimulated glucose utilization in the sucrose-fed animals.
The glucose infusion rate required to maintain euglycemia was significantly lower in the sucrose-fed animals (control versus sucrose: 0.143 k 0.050 versus 0.077 2 0.030 mmol/kg/min, 25.9 2 9.5 versus 13.8 2 5.6 mg/kg/ min). The marked difference in both whole-body glucose utilization and the glucose infusion rate confirms the presence of insulin resistance in the sucrose-fed animals. The glucose infusion rate is an index of whole-body glucose utilization. However, in this study, to measure total glucose production, or R,, 6-"-glucose was also infused during euglycemic hyperinsulinemia. R, was uniformly lower than the glucose infusion rate (data not 
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shown), so that the difference between total production (R,) and the glucose infusion rate (or residual hepatic endogenous glucose production) was less than zero. This finding has no physiologic meaning but is frequently reported in other clamp studies and has been interpreted to indicate complete suppression of hepatic endogenous glucose production (19). There are several possible causes for underestimation of R, during euglycemic hyperinsulinemia. They are 1) tracer recycling, resulting in overestimation of GSA; 2) distinction in metabolism of labeled and unlabeled glucose; and 3) methodologic errors such as the "steady state" during euglycemic hyperinsulinemia being unstable; inadequate removal of tritium-labeled water, causing overestimation of GSA; and the presence of tritium-labeled three-carbon metabolites (lactate), causing overestimation of GSA.
DISCUSSION
This study demonstrates that consumption of a diet in which complex carbohydrate has been replaced by sucrose causes both elevated blood pressure and insulin resistance in juvenile rats with no genetic predisposition to either condition. These findings have been reported in adult rats fed either a sucrose-or fructose-enriched diet (6, 7). It was not obvious, however, that juvenile Sprague-Dawley rats would be similarly affected by a sucrose diet, because under more normative diet conditions, rat pups are highly insulin sensitive (21).
The control diet and the sucrose-enriched diet were similar in all respects, specifically total carbohydrate content; sodium, potassium, and calcium content; and caloric content. The two groups of animals consumed similar daily amounts of diet per kg of body weight; therefore, the only dietary difference was carbohydrate calories provided by sucrose instead of starch (dextrin).
Although blood pressure increased with increasing age and body weight in all four diet groups, higher blood pressures were clearly correlated with the sucrose diet in both males and females (Fig. 2) . The higher blood pressure cannot be explained by greater total body weight in the sucrose-fed animals, because there was no difference in weight between control-fed and sucrose-fed rats in each sex group. Body composition was not examined; thus, it is not known if sucrose feeding in weanling rats resulted in a greater percentage of adipose tissue at the expense of other tissues. This is relevant because increased adipose mass has long been associated with decreased insulin-stimulated glucose utilization and insulin resistance (22) and with elevation in blood pressure (23). There are other reports of body composition analyses on rats fed sucrose-enriched diets. Storlien et al. (24) have shown that there are no changes in body composition when 8-wk-old male Wistar rats are maintained on a high-sucrose diet for 4 wk. In a similar protocol, Thorburn et al. (25) found no change in total body composition, or in brown adipose mass, after a 4-wk sucroseenriched diet. Our data are consistent with those of others indicating that increased body mass and increased adipose mass are unlikely explanations for insulin resistance and hypertension that results from a sugar-enriched diet fed to young rats.
Compensatory hyperinsulinemia counteracts impaired peripheral insulin-stimulated glucose utilization and impaired suppression of glucose production by the liver (26). The degree of hyperinsulinemia is an index of the severity of insulin resistance and can be linked to hypertension by several potential mechanisms. DeFronzo (27) showed that hyperinsulinemia results in retention of sodium by the distal tubules of the kidney, which can induce increased intravascular volume and hypertension. In young adults, Falkner et af. (28) demonstrated an association of plasma insulin concentration and blood pressure sensitivity to sodium. In fructose-fed rats, Hwang et af. (29) found elevated concentrations of atrial natriuretic factor and decreased concentrations of aldosterone, findings that are also consistent with a volumeoverload mechanism for hypertension.
Another possible link between hyperinsulinemia and elevated blood pressure is the effect of insulin on the sympathetic nervous system. Young and Landsberg (30) demonstrated a significant increase in norepinephrine turnover in the hearts of Sprague-Dawley rats during sucrose feeding. This effect was abolished during ganglionic blockade, indicating that it was centrally mediated. Although plasma glucose and insulin concentrations were not measured, the experimental protocol relates aberrant metabolism to increased sympathetic nervous system activity. A study in humans that also indicates that hyperinsulinemia in the absence of hypoglycemia may stimulate sympathetic nervous system activity was reported by Anderson et al. (31) , who demonstrated an increase in peripheral nerve discharge during euglycemic hyperinsulinemia.
These hypothetical links between hyperinsulinemia and elevated blood pressure may not be entirely relevant in the study reported here, because the rats did not develop fasting hyperinsulinemia, despite 10 wk of sucrose-enriched feeds. The lack of fasting hyperinsulinemia may be caused by unimpaired insulin clearance by peripheral musculature, despite decreased insulinstimulated glucose utilization. It should be pointed out that the sugar-fed animals in the studies of Storlien et al. (24) or Thorburn et al. (25) also had normal fasting insulin concentrations. Normal fasting insulin concentrations in these sugar-fed rats do not rule out alimented hyperinsulinemia, that is, hyperinsulinemia after ingestion of food. Alimented hyperinsulinemia could be detected with oral glucose tolerance tests, which were not performed in this study.
Earlier work (24, 25) described both the liver and peripheral tissue as the site of insulin resistance in the sugar-fed rat. Our study suggests, but does not prove, that hyperinsulinemia completely suppresses hepatic endogenous glucose production. Suppressible hepatic endogenous glucose production implicates peripheral tissue 
